Management & Regulatory

How Does BeCrop Unlock Soil Secrets for Sustainable Farming?
Management & Regulatory How Does BeCrop Unlock Soil Secrets for Sustainable Farming?

As the pressure mounts to produce food sustainably, advancements in soil technology like BeCrop are critical. Developed by Biome Makers, BeCrop doesn't just analyze soil; it offers a comprehensive picture of the microbial ecosystem that is crucial for soil health and plant growth. With this

Corporate Action Key to Boosting Carbon Market Efficacy
Management & Regulatory Corporate Action Key to Boosting Carbon Market Efficacy

At the cusp of climate crisis mitigation, carbon markets stand as a crucial mechanism in the battle to replenish forests and slash greenhouse emissions. Yet, their functionality hinges on the corporate world's engrossment. The recent "Financing Forest Protection" digital roundtable

Biotech: Key to Sustainable Agriculture Amid Climate Crisis
Management & Regulatory Biotech: Key to Sustainable Agriculture Amid Climate Crisis

As the shadow of climate change extends, sustainable farming is no longer optional but essential. With the world grappling with depleting resources and escalating food demand, breakthroughs in biotech stand at the forefront of agricultural innovation. These advancements herald a new era where

First Wave BioPharma CEO Sells Shares to Cover Tax Duties
Management & Regulatory First Wave BioPharma CEO Sells Shares to Cover Tax Duties

James Sapirstein, the CEO of First Wave BioPharma, Inc., recently conducted an insider transaction involving a modest number of company shares. He sold 174 shares at $4.2294 each, resulting in a total of approximately $735. However, this insider sale was not the outcome of voluntary market actions

Mammalian Biopharmaceutical Service Market Analysis and Trends
Management & Regulatory Mammalian Biopharmaceutical Service Market Analysis and Trends

The Mammalian Biopharmaceutical Service Market is undergoing transformative growth, driven by technological advances and an ever-increasing demand for therapeutic proteins and antibodies. These services encompass biologics' production and development stages, including cell line development,

Can Sutro Biopharma's $75M Offering Fuel Its Cancer Fight?
Management & Regulatory Can Sutro Biopharma's $75M Offering Fuel Its Cancer Fight?

To escalate the war on cancer, Sutro Biopharma has launched a public offering with the goal of raising $75 million. These proceeds are set to bolster Sutro's efforts in creating cutting-edge antibody-drug conjugates (ADCs), which stand at the forefront of its cancer treatment research. By

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later